Clinical Study
Treatment Challenges in Pediatric Stroke Patients
Table 2
Prothrombotic risk factors and underlying clinical diagnosis.
| | Cholesterol° | Triglyceride° | High-CRP | Fibrinogen° | Homocysteine° | Lipoprotein A° | Factor VIIIμ | Factor IXμ | Protein Sα | Protein Cα | Antithrombin IIIα | APCR | Factor V Leidenβ | MTHFRβ | Prothrombinβ | Total |
| | Idiopathic | 2 | 3 | 1 | — | 4 | 5 | 11 | 5 | 7 | 5 | 1 | 7 | 6 | 9 | 2 | 59 | | Encephalitis | — | — | — | 1 | 1 | 1 | 5 | — | — | 1 | — | — | 1 | — | 1 | 9 | | Malignancy | — | — | — | — | 2 | 1 | 3 | — | 1 | — | — | — | 1 | 1 | — | 4 | | Trauma | — | — | — | — | — | — | — | — | — | 1 | — | 1 | 1 | — | — | 2 | | Congenital heart disease | — | — | — | — | 3 | 1 | 4 | 3 | 1 | 5 | 1 | 1 | — | 2 | — | 9 | | Hypernatremic dehydration | — | — | — | — | — | — | — | — | — | — | — | — | — | 1 | 1 | 3 | | Moya Moya disease | — | — | — | — | 1 | — | — | — | — | — | — | — | — | 1 | — | 3 | | Perinatal hypoxia | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1 | | Antiphospholipid antibody | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1 | | Undergone varicella | 1 | 1 | — | — | — | — | — | — | — | — | — | — | — | — | — | 2 | | Isolated glucocorticoid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1 | | Congenital adrenal hyperplasia | — | — | — | — | 1 | 1 | 1 | 1 | 1 | 1 | — | — | 1 | 1 | — | 3 | | Arterio-venous malformation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1 | | Cyclosporin toxicity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1 | | Purulent meningitis | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 2 | | Phenylketonuria | — | — | — | — | — | 1 | 1 | — | — | 1 | — | — | — | — | — | 1 | | Rheumatic heart disease | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1 | | Thalassemia major and BMT | — | — | — | — | 1 | — | — | — | — | — | — | — | — | 1 | — | 1 | | Behçet’s disease | — | — | — | 2 | 1 | 1 | 1 | — | — | — | — | 1 | — | — | — | 2 | | Late-onset hemorrhagic disease of newborn | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 1 | | Megaloblastic anemia | — | — | — | 1 | 1 | — | 1 | — | — | — | — | — | 1 | 1 | — | 1 |
| | Total | — | 108 |
|
|
= bone marrow transplantation, °=hyper, μ=increased, α=deficiency, β=mutation.
|
